Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
PharmaEssentia
PharmaEssentia
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Besremi
Ropeginterferon alfa-2b
2021-11-12
Polycythemia vera
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ropeginterferon alfa-2b
hepatitis b
,
chronic hepatitis
,
healthy volunteers/patients
,
chronic hepatitis d
,
hepatitis
,
hepatitis a
,
hepatitis d
,
coinfection
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
chronic hepatitis b
,
hepatitis c
,
chronic hepatitis c
,
infections
,
communicable diseases
,
essential thrombocythemia
,
thrombocytosis
,
primary myelofibrosis
,
polycythemia vera
,
polycythemia
,
myeloproliferative disorders
,
herpesviridae infections
Benzocaine
neoplasms
Calcium carbonate
essential thrombocythemia
,
thrombocytosis
Albumin
neoplasms
Antithrombin iii
polycythemia vera
,
polycythemia
,
myeloproliferative disorders
,
primary myelofibrosis
Ademetionine
myeloproliferative disorders
,
polycythemia vera
,
polycythemia
Tenofovir
hepatitis d
,
coinfection
,
hepatitis
,
hepatitis a
Albinterferon alfa-2b
chronic hepatitis d
,
hepatitis b
,
hepatitis d
,
chronic hepatitis
,
hepatitis
,
hepatitis a
,
hepatitis c
,
chronic hepatitis c
,
polycythemia vera
,
polycythemia
,
infections
,
chronic hepatitis b
,
communicable diseases
Fendrix
hepatitis b
,
chronic hepatitis b
,
chronic hepatitis
,
infections
,
chronic hepatitis d
,
communicable diseases
,
hepatitis
,
hepatitis a
,
hepatitis d
,
coinfection
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
herpesviridae infections
Q2w
chronic hepatitis d
,
hepatitis b
,
chronic hepatitis
,
hepatitis
,
hepatitis a
,
hepatitis d
,
coinfection
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
infections
,
chronic hepatitis b
,
communicable diseases
,
essential thrombocythemia
,
thrombocytosis
,
hepatitis c
,
chronic hepatitis c
,
polycythemia vera
,
polycythemia
Tums
essential thrombocythemia
,
thrombocytosis
Pcv
polycythemia vera
,
polycythemia
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use